Search

SIGA Technologies Inc

Geschlossen

BrancheGesundheitswesen

3.12 -0.32

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.1

Max

3.15

Schlüsselkennzahlen

By Trading Economics

Einkommen

-34M

-3.5M

Verkäufe

2.4M

6.2M

KGV

Branchendurchschnitt

12.429

62.58

EPS

-0.048

Gewinnspanne

-55.334

Angestellte

49

EBITDA

5.6M

-3.9M

Dividenden

By Acuity

Nächstes Ergebnis

4. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-82M

250M

Vorheriger Eröffnungskurs

3.44

Vorheriger Schlusskurs

3.12

Nachrichtenstimmung

By Acuity

50%

50%

152 / 340 Ranking in Healthcare

SIGA Technologies Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Juli 2026, 19:31 UTC

SIGA Technologies shares are higher amid a pullback in crude oil prices, easing inflation concerns, though the stock remains near its one-month range low.

23. Juli 2026, 00:01 UTC

SIGA Technologies shares are higher in after-market trading, advancing notably since Wednesday's close, despite being below its 20-day moving average.

22. Juli 2026, 23:01 UTC

SIGA Technologies Inc shares are higher in after-market trading, rising notably since Wednesday's close amid broader market concerns over oil prices and geopolitical tensions.

21. Juli 2026, 17:21 UTC

SIGA Technologies Inc shares are higher today, amid positive market sentiment in Asia despite earlier downward movement and no specific company news identified.

20. Juli 2026, 18:26 UTC

Shares of SIGA Technologies are higher during Monday's session, advancing since Friday's close amid broader market concerns over rising yields and inflation linked to oil prices.

Peer-Vergleich

Kursveränderung

SIGA Technologies Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Stimmung

By Acuity

152 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über SIGA Technologies Inc

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
help-icon Live chat